Company

Fuzhou Luyan Pharmacy Secures Exclusive Greater China Rights to French Synergia Brand in Strategic Partnership with Curae LAB
Luyan Pharmacy

Fuzhou Luyan Pharmacy Secures Exclusive Greater China Rights to French Synergia Brand in Strategic Partnership with Curae LAB

Fuzhou Luyan Pharmacy Co., Ltd. ("Luyan Pharma") signed an exclusive strategic cooperation agreement with Curae LAB, a subsidiary of the French GTH Group, for the Synergia brand in Greater China.…

Hangzhou Eli Radiopharma Closes Nearly RMB 400 Million Series A Round – Capital Earmarked for Radiopharmaceutical Pipeline and Radiotheranostic Platform Buildout

Hangzhou Eli Radiopharma Closes Nearly RMB 400 Million Series A Round – Capital Earmarked for Radiopharmaceutical Pipeline and Radiotheranostic Platform Buildout

Amgen's Dazodalibep Hits Phase 3 Milestone in OASIZ‑301 – First Trial to Show Clinically Meaningful Improvement in Systemic Sjögren's Disease Activity

Amgen’s Dazodalibep Hits Phase 3 Milestone in OASIZ‑301 – First Trial to Show Clinically Meaningful Improvement in Systemic Sjögren’s Disease Activity

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Quantum Hi-Tech (ChemPartner) Plans to Raise Over RMB 930 Million in Private Placement
ChemPartner PharmatechCRO / CMO / CDMO

Quantum Hi-Tech (ChemPartner) Plans to Raise Over RMB 930 Million in Private Placement

AbbVie Acquires Roche's Nimble Therapeutics to Boost Immunology Pipeline
AbbVieBiotech

AbbVie Acquires Roche’s Nimble Therapeutics to Boost Immunology Pipeline

iFlytek's Xunfei Healthcare Passes HKEX Hearing for AI-Powered Medical IPO
iFlytekIPO

iFlytek’s Xunfei Healthcare Passes HKEX Hearing for AI-Powered Medical IPO

Innovent Biologics Partners with Eli Lilly for Distribution of Jaypirca in China
CancerEli Lilly

Innovent Biologics Partners with Eli Lilly for Distribution of Jaypirca in China

Show More